Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,581 to 1,600 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise. | Microorganisms | 2021 | 34198973 | PubTator, text mining | PubMed |
| Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease. | Biochem J | 2021 | 34198327 | PubTator, text mining | PubMed |
| Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease. | Biochem J | 2021 | 34198326 | PubTator, text mining | PubMed |
| Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease. | Biochem J | 2021 | 34198324 | PubTator, text mining | PubMed |
| Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase. | Biochem J | 2021 | 34198322 | PubTator, text mining | PubMed |
| An all-out assault on SARS-CoV-2 replication. | Biochem J | 2021 | 34198321 | PubTator, text mining | PubMed |
| A brief molecular insight of COVID-19: epidemiology, clinical manifestation, molecular mechanism, cellular tropism and immuno-pathogenesis. | Mol Cell Biochem | 2021 | 34195882 | PubTator, text mining | PubMed |
| Restriction of SARS-CoV-2 replication by targeting programmed -1 ribosomal frameshifting. | Proc Natl Acad Sci U S A | 2021 | 34185680 | PubTator, text mining | PubMed |
| Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs. | Cell | 2021 | 34171305 | PubTator, text mining | PubMed |
| An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia. | Curr Biol | 2021 | 34171302 | PubTator, text mining | PubMed |
| Rapid structure-based identification of potential SARS-CoV-2 main protease inhibitors. | Future Med Chem | 2021 | 34169728 | PubTator, text mining | PubMed |
| Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19. | Sci Rep | 2021 | 34168183 | PubTator, text mining | PubMed |
| SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms. | PLoS One | 2021 | 34166398 | PubTator, text mining | PubMed |
| Understanding the Molecular Biology of SARS-CoV-2 and the COVID-19 Pandemic: A Review. | Infect Drug Resist | 2021 | 34163190 | PubTator, text mining | PubMed |
| Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease. | Structure | 2021 | 34161756 | PubTator, text mining | PubMed |
| Exploring the Druggability of Conserved RNA Regulatory Elements in the SARS-CoV-2 Genome. | Angew Chem Int Ed Engl | 2021 | 34161644 | PubTator, text mining | PubMed |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Genome Sequencing from Post-Mortem Formalin-Fixed, Paraffin-Embedded Lung Tissues. | J Mol Diagn | 2021 | 34153515 | PubTator, text mining | PubMed |
| Efficiency Improvements and Discovery of New Substrates for a SARS-CoV-2 Main Protease FRET Assay. | SLAS Discov | 2021 | 34151620 | PubTator, text mining | PubMed |
| COVID-19: In silico identification of potent α-ketoamide inhibitors targeting the main protease of the SARS-CoV-2. | J Mol Struct | 2021 | 34149065 | PubTator, text mining | PubMed |
| Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades. | Infect Genet Evol | 2021 | 34147651 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=80